Genome-wide Methyl-Seq analysis of blood-brain targets of glucocorticoid exposure

Fayaz Seifuddin, Gary S Wand, Olivia Cox, Mehdi Pirooznia, Laura Moody, Xiaoju Yang, Jonathan Tai, Gretha Boersma, Kellie Tamashiro, Peter P Zandi, Richard Lee

Research output: Contribution to journalArticle

Abstract

Chronic exposure to glucocorticoids (GCs) can lead to psychiatric complications through epigenetic mechanisms such as DNA methylation (DNAm). We sought to determine whether epigenetic changes in a peripheral tissue can serve as a surrogate for those in a relatively inaccessible tissue such as the brain. DNA extracted from the hippocampus and blood of mice treated with GCs or vehicle solution was assayed using a genome-wide DNAm platform (Methyl-Seq) to identify differentially methylated regions (DMRs) induced by GC treatment. We observed that ∼70% of the DMRs in both tissues lost methylation following GC treatment. Of the 3,095 DMRs that mapped to the same genes in both tissues, 1,853 DMRs underwent DNAm changes in the same direction. Interestingly, only 209 DMRs (<7%) overlapped in genomic coordinates between the 2 tissues, suggesting tissue-specific differences in GC-targeted loci. Pathway analysis showed that the DMR-associated genes were members of pathways involved in metabolism, immune function, and neurodevelopment. Also, changes in cell type composition of blood and brain were examined by fluorescence-activated cell sorting. Separation of the cortex into neuronal and non-neuronal fractions and the leukocytes into T-cells, B-cells, and neutrophils showed that GC-induced methylation changes primarily occurred in neurons and T-cells, with the blood tissue also undergoing a shift in the proportion of constituent cell types while the proportion of neurons and glia in the brain remained stable. From the current pilot study, we found that despite tissue-specific epigenetic changes and cellular heterogeneity, blood can serve as a surrogate for GC-induced changes in the brain.

Original languageEnglish (US)
Pages (from-to)1-16
Number of pages16
JournalEpigenetics
DOIs
StateAccepted/In press - Jul 26 2017

Fingerprint

Glucocorticoids
Genome
Brain
DNA Methylation
Epigenomics
Methylation
T-Lymphocytes
Neurons
Neuroglia
Genes
Psychiatry
Hippocampus
Blood Cells
Flow Cytometry
Neutrophils
Leukocytes
B-Lymphocytes
DNA

Keywords

  • Biomarker
  • blood-brain correlation
  • Cushing's disease
  • DNA methylation
  • epigenetics
  • glucocorticoids
  • tissue heterogeneity

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research

Cite this

Genome-wide Methyl-Seq analysis of blood-brain targets of glucocorticoid exposure. / Seifuddin, Fayaz; Wand, Gary S; Cox, Olivia; Pirooznia, Mehdi; Moody, Laura; Yang, Xiaoju; Tai, Jonathan; Boersma, Gretha; Tamashiro, Kellie; Zandi, Peter P; Lee, Richard.

In: Epigenetics, 26.07.2017, p. 1-16.

Research output: Contribution to journalArticle

Seifuddin, Fayaz ; Wand, Gary S ; Cox, Olivia ; Pirooznia, Mehdi ; Moody, Laura ; Yang, Xiaoju ; Tai, Jonathan ; Boersma, Gretha ; Tamashiro, Kellie ; Zandi, Peter P ; Lee, Richard. / Genome-wide Methyl-Seq analysis of blood-brain targets of glucocorticoid exposure. In: Epigenetics. 2017 ; pp. 1-16.
@article{109751fcc2aa4f78affd0c215d25a68a,
title = "Genome-wide Methyl-Seq analysis of blood-brain targets of glucocorticoid exposure",
abstract = "Chronic exposure to glucocorticoids (GCs) can lead to psychiatric complications through epigenetic mechanisms such as DNA methylation (DNAm). We sought to determine whether epigenetic changes in a peripheral tissue can serve as a surrogate for those in a relatively inaccessible tissue such as the brain. DNA extracted from the hippocampus and blood of mice treated with GCs or vehicle solution was assayed using a genome-wide DNAm platform (Methyl-Seq) to identify differentially methylated regions (DMRs) induced by GC treatment. We observed that ∼70{\%} of the DMRs in both tissues lost methylation following GC treatment. Of the 3,095 DMRs that mapped to the same genes in both tissues, 1,853 DMRs underwent DNAm changes in the same direction. Interestingly, only 209 DMRs (<7{\%}) overlapped in genomic coordinates between the 2 tissues, suggesting tissue-specific differences in GC-targeted loci. Pathway analysis showed that the DMR-associated genes were members of pathways involved in metabolism, immune function, and neurodevelopment. Also, changes in cell type composition of blood and brain were examined by fluorescence-activated cell sorting. Separation of the cortex into neuronal and non-neuronal fractions and the leukocytes into T-cells, B-cells, and neutrophils showed that GC-induced methylation changes primarily occurred in neurons and T-cells, with the blood tissue also undergoing a shift in the proportion of constituent cell types while the proportion of neurons and glia in the brain remained stable. From the current pilot study, we found that despite tissue-specific epigenetic changes and cellular heterogeneity, blood can serve as a surrogate for GC-induced changes in the brain.",
keywords = "Biomarker, blood-brain correlation, Cushing's disease, DNA methylation, epigenetics, glucocorticoids, tissue heterogeneity",
author = "Fayaz Seifuddin and Wand, {Gary S} and Olivia Cox and Mehdi Pirooznia and Laura Moody and Xiaoju Yang and Jonathan Tai and Gretha Boersma and Kellie Tamashiro and Zandi, {Peter P} and Richard Lee",
year = "2017",
month = "7",
day = "26",
doi = "10.1080/15592294.2017.1334025",
language = "English (US)",
pages = "1--16",
journal = "Epigenetics",
issn = "1559-2294",
publisher = "Landes Bioscience",

}

TY - JOUR

T1 - Genome-wide Methyl-Seq analysis of blood-brain targets of glucocorticoid exposure

AU - Seifuddin, Fayaz

AU - Wand, Gary S

AU - Cox, Olivia

AU - Pirooznia, Mehdi

AU - Moody, Laura

AU - Yang, Xiaoju

AU - Tai, Jonathan

AU - Boersma, Gretha

AU - Tamashiro, Kellie

AU - Zandi, Peter P

AU - Lee, Richard

PY - 2017/7/26

Y1 - 2017/7/26

N2 - Chronic exposure to glucocorticoids (GCs) can lead to psychiatric complications through epigenetic mechanisms such as DNA methylation (DNAm). We sought to determine whether epigenetic changes in a peripheral tissue can serve as a surrogate for those in a relatively inaccessible tissue such as the brain. DNA extracted from the hippocampus and blood of mice treated with GCs or vehicle solution was assayed using a genome-wide DNAm platform (Methyl-Seq) to identify differentially methylated regions (DMRs) induced by GC treatment. We observed that ∼70% of the DMRs in both tissues lost methylation following GC treatment. Of the 3,095 DMRs that mapped to the same genes in both tissues, 1,853 DMRs underwent DNAm changes in the same direction. Interestingly, only 209 DMRs (<7%) overlapped in genomic coordinates between the 2 tissues, suggesting tissue-specific differences in GC-targeted loci. Pathway analysis showed that the DMR-associated genes were members of pathways involved in metabolism, immune function, and neurodevelopment. Also, changes in cell type composition of blood and brain were examined by fluorescence-activated cell sorting. Separation of the cortex into neuronal and non-neuronal fractions and the leukocytes into T-cells, B-cells, and neutrophils showed that GC-induced methylation changes primarily occurred in neurons and T-cells, with the blood tissue also undergoing a shift in the proportion of constituent cell types while the proportion of neurons and glia in the brain remained stable. From the current pilot study, we found that despite tissue-specific epigenetic changes and cellular heterogeneity, blood can serve as a surrogate for GC-induced changes in the brain.

AB - Chronic exposure to glucocorticoids (GCs) can lead to psychiatric complications through epigenetic mechanisms such as DNA methylation (DNAm). We sought to determine whether epigenetic changes in a peripheral tissue can serve as a surrogate for those in a relatively inaccessible tissue such as the brain. DNA extracted from the hippocampus and blood of mice treated with GCs or vehicle solution was assayed using a genome-wide DNAm platform (Methyl-Seq) to identify differentially methylated regions (DMRs) induced by GC treatment. We observed that ∼70% of the DMRs in both tissues lost methylation following GC treatment. Of the 3,095 DMRs that mapped to the same genes in both tissues, 1,853 DMRs underwent DNAm changes in the same direction. Interestingly, only 209 DMRs (<7%) overlapped in genomic coordinates between the 2 tissues, suggesting tissue-specific differences in GC-targeted loci. Pathway analysis showed that the DMR-associated genes were members of pathways involved in metabolism, immune function, and neurodevelopment. Also, changes in cell type composition of blood and brain were examined by fluorescence-activated cell sorting. Separation of the cortex into neuronal and non-neuronal fractions and the leukocytes into T-cells, B-cells, and neutrophils showed that GC-induced methylation changes primarily occurred in neurons and T-cells, with the blood tissue also undergoing a shift in the proportion of constituent cell types while the proportion of neurons and glia in the brain remained stable. From the current pilot study, we found that despite tissue-specific epigenetic changes and cellular heterogeneity, blood can serve as a surrogate for GC-induced changes in the brain.

KW - Biomarker

KW - blood-brain correlation

KW - Cushing's disease

KW - DNA methylation

KW - epigenetics

KW - glucocorticoids

KW - tissue heterogeneity

UR - http://www.scopus.com/inward/record.url?scp=85026349742&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85026349742&partnerID=8YFLogxK

U2 - 10.1080/15592294.2017.1334025

DO - 10.1080/15592294.2017.1334025

M3 - Article

C2 - 28557603

AN - SCOPUS:85026349742

SP - 1

EP - 16

JO - Epigenetics

JF - Epigenetics

SN - 1559-2294

ER -